BeadArray™-Based solutions for enabling the promise of pharmacogenomics

BioTechniques

Volumn 39, Issue , 2005, Pages 583-588

  Fan, Jian Bing ^a   Hu, Sean X ^a,b   Craumer, William C ^a   Barker, David L ^a  

^a ILLUMINA INC   (United States)

^b IMS Management Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFOCAL LASER MICROSCOPY; COST EFFECTIVENESS ANALYSIS; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; HUMAN; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; BIOTECHNOLOGY; CHEMISTRY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENOTYPE; INSTRUMENTATION; METABOLISM; METHODOLOGY; PHARMACOGENETICS; TREATMENT OUTCOME; TUMOR CELL LINE; ANIMAL; HEALTH CARE COST; PROBLEM SOLVING; PROCEDURES; TRENDS;

COMPLEMENTARY DNA; DNA; RNA;

BIOTECHNOLOGY; CELL LINE, TUMOR; DNA; DNA METHYLATION; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA; TREATMENT OUTCOME; VARIATION (GENETICS); ANIMALS; HEALTH CARE SECTOR; PROBLEM SOLVING;

EID: 32944463486     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/000112047     Document Type: Article

References (55)

1. Frueh, F. W., F. Goodsaid, A. Rudman, S. M. Huang, and L. J. Lesko. 2005. The need for education in pharmacogenomics: a regulatory perspective. Pharmacogenomics J. 5: 218-220.
2. Lesko, L. J. and J. Woodcock. 2004. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat. Rev. Drug Discov. 3: 763-769.
3. The International HapMap Consortium. 2003. The International HapMap Project. Nature 426: 789-796.
4. Oliphant, A., D. L. Barker, J. R. Stuelpnagel, and M. S. Chee. 2002. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. BioTechniques Suppl: 56-61.
5. Gunderson, K. L., S. Kruglyak, M. S. Graige, F. Garcia, B. G. Kermani, C. Zhao, D. Che, T. Dickinson, et al. 2004. Decoding randomly ordered DNA arrays. Genome Res. 14: 870-877.
6. Barker, D. L., D. Theriault, D. Che, T. Dickinson, R. Shen, and R. Kain. 2003. Self-assembled random arrays: High-performance imaging and genomics applications on a high-density microarray platform. Proc. SPIE 4966: 1-11.
7. Gunderson, K. L., F. J. Steemers, G. Lee, L. G. Mendoza, and M. S. Chee. 2005. A genome-wide scalable SNP genotyping assay using microarray technology. Nat. Genet. 37: 549-554.
8. Fan, J. B., A. Oliphant, R. Shen, B. G. Kermani, F. Garcia, K. L. Gunderson, M. Hansen, F. Steemers, et al. 2003. Highly parallel SNP genotyping. Cold Spring Harb. Symp. Quant. Biol. 68: 69-78.
9. Shen, R., J. B. Fan, D. Campbell, W. Chang, J. Chen, D. Doucet, J. Yeakley, M. Bibikova, et al. 2005. High-throughput SNP genotyping on universal bead arrays. Mutat. Res. 573: 70-82.
10. Barker, D. L., M. S. Hansen, A. F. Faruqi, D. Giannola, O. R. Irsula, R. S. Lasken, M. Latterich, V. Makarov, et al. 2004. Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res. 14: 901-907.
11. Golub, T. R., D. K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J. P. Mesirov, H. Coller, M. L. Loh, et al. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
12. Perou, C. M., T. Sorlie, M. B. Eisen, M. van de Rijn, S. S. Jeffrey, C. A. Rees, J. R. Pollack, D. T. Ross, et al. 2000. Molecular portraits of human breast tumours. Nature 406: 747-752.
13. Welsh, J. B., L. M. Sapinoso, A. I. Su, S. G. Kern, J. Wang-Rodriguez, C. A. Moskaluk, H. F. Frierson, Jr., and G. M. Hampton. 2001. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61: 5974-5978.
14. Dhanasekaran, S. M., T. R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K. J. Pienta, M. A. Rubin, et al. 2001. Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826.
15. West, M., C. Blanchette, H. Dressman, E. Huang, S. Ishida, R. Spang, H. Zuzan, J. A. Olson, Jr., et al. 2001. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. USA 98: 11462-11467.
16. van 't Veer, L. J., H. Dai, M. J. van de Vijver, Y. D. He, A. A. Hart, M. Mao, H. L. Peterse, K. van der Kooy, et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
17. Welsh, J. B., L. M. Sapinoso, S. G. Kern, D. A. Brown, T. Liu, A. R. Bauskin, R. L. Ward, N. J. Hawkins, et al. 2003. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. USA 100: 3410-3415.
18. Chuaqui, R. F., R. F. Bonner, C. J. Best, J. W. Gillespie, M. J. Flaig, S. M. Hewitt, J. L. Phillips, D. B. Krizman, et al. 2002. Post-analysis follow-up and validation of microarray experiments. Nat. Genet. 32(Suppl): 509-514.
19. van de Vijver, M. J., Y. D. He, L. J. van't Veer, H. Dai, A. A. Hart, D. W. Voskuil, G. J. Schreiber, J. L. Peterse, et al. 2002. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347: 1999-2009.
20. Stuart, R. O., W. Wachsman, C. C. Berry, J. Wang-Rodriguez, L. Wasserman, I. Klacansky, D. Masys, K. Arden, et al. 2004. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc. Natl. Acad. Sci. USA 101: 615-620.
21. Lossos, I. S., D. K. Czerwinski, A. A. Alizadeh, M. A. Wechser, R. Tibshirani, D. Botstein, and R. Levy. 2004. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350: 1828-1837.
22. Bullinger, L., K. Dohner, E. Bair, S. Frohling, R. F. Schlenk, R. Tibshirani, H. Dohner, and J. R. Pollack. 2004. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 350: 1605-1616.
23. Ramaswamy, S. 2004. Translating cancer genomics into clinical oncology. N. Engl. J. Med. 350: 1814-1816.
24. Paik, S., S. Shak, G. Tang, C. Kim, J. Baker, M. Cronin, F. L. Baehner, M. G. Walker, et al. 2004. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351: 2817-2826.
25. Wang, Y., J. G. Klijn, Y. Zhang, A. M. Sieuwerts, M. P. Look, F. Yang, D. Talantov, M. Timmermans, et al. 2005. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
26. Lewis, F., N. J. Maughan, V. Smith, K. Hillan, and P. Quirke. 2001. Unlocking the archive-gene expression in paraffin-embedded tissue. J. Pathol. 195: 66-71.
27. Ramaswamy, S. and T. R. Golub. 2002. DNA microarrays in clinical oncology. J. Clin. Oncol. 20: 1932-1941.
28. Abrahamsen, H. N., T. Steiniche, E. Nexo, S. J. Hamilton-Dutoit, and B. S. Sorensen. 2003. Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients. J. Mol. Diagn. 5: 34-41.
29. Karsten, S. L., V. M. Van Deerlin, C. Sabatti, L. H. Gill, and D. H. Geschwind. 2002. An evaluation of tyramide signal amplification and archived fixed and frozen tissue in microarray gene expression analysis. Nucleic Acids Res. 30: E4.
30. Daigo, Y., S. F. Chin, K. L. Gorringe, L. G. Bobrow, B. A. Ponder, P. D. Pharoah, and C. Caldas. 2001. Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: a new approach for the molecular analysis of paraffin-embedded cancer tissue. Am. J. Pathol. 158: 1623-1631.
31. Godfrey, T. E., S. H. Kim, M. Chavira, D. W. Ruff, R. S. Warren, J. W. Gray, and R. H. Jensen. 2000. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction. J. Mol. Diagn. 2: 84-91.
32. Lehmann, U., S. Glockner, W. Kleeberger, H. F. von Wasielewski, and H. Kreipe. 2000. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am. J. Pathol. 156: 1855-1864.
33. Palmieri, G., P. A. Ascierto, A. Cossu, N. Mozzillo, M. L. Motti, S. M. Satriano, G. Botti, C. Caraco, et al. 2001. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J. Clin. Oncol. 19: 1437-1443.
34. Specht, K., T. Richter, U. Muller, A. Walch, M. Werner, and H. Hofler. 2001. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am. J. Pathol. 158: 419-429.
35. Cronin, M., M. Pho, D. Dutta, J. C. Stephans, S. Shak, M. C. Kiefer, J. M. Esteban, and J. B. Baker. 2004. Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am. J. Pathol. 164: 35-42.
36. Fan, J. B., J. M. Yeakley, M. Bibikova, E. Chudin, E. Wickham, J. Chen, D. Doucet, P. Rigault, et al. 2004. A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res. 14: 878-885.
37. Bibikova, M., J. M. Yeakley, E. Chudin, J. Chen, E. Wickham, J. Wang-Rodriguez, and J. B. Fan. 2004. Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis. Clin. Chem. 50: 2384-2386.
38. Bibikova, M., D. Talantov, E. Chudin, J. M. Yeakley, J. Chen, D. Doucet, E. Wickham, D. Atkins, et al. 2004. Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am. J. Pathol. 165: 1799-1807.
39. Egger, G., G. Liang, A. Aparicio, and P. A. Jones. 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
40. Laird, P. W. and R. Jaenisch. 1996. The role of DNA methylation in cancer genetic and epigenetics. Annu. Rev. Genet. 30: 441-464.
41. Li, E., C. Beard, and R. Jaenisch. 1993. Role for DNA methylation in genomic imprinting. Nature 366: 362-365.
42. Balmain, A., J. Gray, and B. Ponder. 2003. The genetics and genomics of cancer. Nat. Genet. 33(Suppl): 238-244.
43. Baylin, S. B. and J. G. Herman. 2000. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16: 168-174.
44. Feinberg, A. P. and B. Tycko. 2004. The history of cancer epigenetics. Nat. Rev. Cancer 4: 143-153.
45. Esteller, M. 2002. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427-5440.
46. Herman, J. G. and S. B. Baylin. 2003. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349: 2042-2054.
47. Alaminos, M., V. Davalos, N. K. Cheung, W. L. Gerald, and M. Esteller. 2004. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J. Natl. Cancer Inst. 96: 1208-1219.
48. Martens, J. W., I. Nimmrich, T. Koenig, M. P. Look, N. Harbeck, F. Model, A. Kluth, J. Bolt-de Vries, et al. 2005. Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res. 65: 4101-4117.
49. Widschwendter, M., K. D. Siegmund, H. M. Muller, H. Fiegl, C. Marth, E. Muller-Holzner, P. A. Jones, and P. W. Laird. 2004. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res. 64: 3807-3813.
50. Esteller, M., M. Sanchez-Cespedes, R. Rosell, D. Sidransky, S. B. Baylin, and J. G. Herman. 1999. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59: 67-70.
51. Herman, J. G. 2004. Circulating methylated DNA. Ann. NY Acad. Sci. 1022: 33-39.
52. Muller, H. M., H. Fiegl, A. Widschwendter, and M. Widschwendter. 2004. Prognostic DNA methylation marker in serum of cancer patients. Ann. NY Acad. Sci. 1022: 44-49.
53. Weinshilboum, R. 2003. Inheritance and drug response. N. Engl. J. Med. 348: 529-537.
54. Evans, W. E. and H. L. McLeod. 2003. Pharmacogenomics-drug disposition, drug targets, and side effects. N. Engl. J. Med. 348: 538-549.
55. Roses, A. D. 2002. Genome-based pharmacogenetics and the pharmaceutical industry. Nat. Rev. Drug Discov. 1: 541-549.